REFERENCES
1. Rademakers R, Baker M, Nicholson AM, et al. Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Nat Genet. 2012;44:200-5.
2. Xu Z, Rao Y, Huang Y, et al. Efficient strategies for microglia replacement in the central nervous system. Cell Rep. 2020;32:108041.
3. Wu J, Wang Y, Li X, et al. Microglia replacement halts the progression of microgliopathy in mice and humans. Science. 2025;389:eadr1015.
4. Bergner CG, Schäfer L, Vucinic V, et al. Case report: treatment of advanced CSF1-receptor associated leukoencephalopathy with hematopoietic stem cell transplant. Front Neurol. 2023;14:1163107.
5. Dulski J, Heckman MG, White LJ, Żur-Wyrozumska K, Lund TC, Wszolek ZK. Hematopoietic stem cell transplantation in CSF1R-related leukoencephalopathy: retrospective study on predictors of outcomes. Pharmaceutics. 2022;14:2778.
6. Chadarevian JP, Hasselmann J, Lahian A, et al. Therapeutic potential of human microglia transplantation in a chimeric model of CSF1R-related leukoencephalopathy. Neuron. 2024;112:2686-2707.e8.
7. Li X, Hu B, Wu C, et al. A strategy of microglia replacement alleviates microgliopathy in a CSF1R I794T hotspot mutation mouse model of CSF1R-related disorder. Cell Rep Med. 2026;7:102641.
8. Yska HAF, Golse M, Beerepoot S, et al.; and the International CSF1R-RD Working Group. Hematopoietic stem cell transplantation in an international cohort of colony stimulating factor-1 receptor (CSF1R)-related disorder. Mov Disord. 2025;40:1826-35.
